- Home
- PFIS vs ADPT Comparison
PFIS vs ADPT Comparison
Compare PFIS & ADPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PFIS
- ADPT
- Stock Information
- Founded
- PFIS 1905
- ADPT 2009
- Country
- PFIS United States
- ADPT United States
- Employees
- PFIS N/A
- ADPT N/A
- Industry
- PFIS Major Banks
- ADPT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PFIS Finance
- ADPT Health Care
- Exchange
- PFIS Nasdaq
- ADPT Nasdaq
- Market Cap
- PFIS 441.9M
- ADPT 685.7M
- IPO Year
- PFIS N/A
- ADPT 2019
- Fundamental
- Price
- PFIS $49.48
- ADPT $4.64
- Analyst Decision
- PFIS Hold
- ADPT Buy
- Analyst Count
- PFIS 1
- ADPT 5
- Target Price
- PFIS $47.00
- ADPT $7.00
- AVG Volume (30 Days)
- PFIS 13.9K
- ADPT 1.2M
- Earning Date
- PFIS 10-28-2024
- ADPT 11-07-2024
- Dividend Yield
- PFIS 3.81%
- ADPT N/A
- EPS Growth
- PFIS N/A
- ADPT N/A
- EPS
- PFIS 2.41
- ADPT N/A
- Revenue
- PFIS $90,823,000.00
- ADPT $168,766,000.00
- Revenue This Year
- PFIS N/A
- ADPT $3.47
- Revenue Next Year
- PFIS $33.98
- ADPT $20.01
- P/E Ratio
- PFIS $20.17
- ADPT N/A
- Revenue Growth
- PFIS N/A
- ADPT N/A
- 52 Week Low
- PFIS $36.26
- ADPT $2.28
- 52 Week High
- PFIS $51.00
- ADPT $5.80
- Technical
- Relative Strength Index (RSI)
- PFIS 66.77
- ADPT 45.13
- Support Level
- PFIS $45.45
- ADPT $4.73
- Resistance Level
- PFIS $48.88
- ADPT $5.13
- Average True Range (ATR)
- PFIS 1.23
- ADPT 0.32
- MACD
- PFIS 0.38
- ADPT -0.06
- Stochastic Oscillator
- PFIS 99.63
- ADPT 3.35
About PFIS Peoples Financial Services Corp.
Peoples Financial Services Corp is a bank holding company operating through its subsidiaries. The bank provides a full range of financial services. Its products and services include checking accounts, business accounts, savings accounts, loan products, money market accounts, mortgages, chip-enabled debit cards, credit card processing, and visa master card and advisory services. Its loan portfolio includes Commercial loans, which consist of commercial, commercial real estate, municipal, and other related tax-free loans; and retail loans, which include residential real estate and other consumer loans. The company mainly operates in the United States in Pennsylvania.
About ADPT Adaptive Biotechnologies Corporation
Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).